WCG Clinical

JANUARY 4, 2024

PRINCETON, NJ, January 4, 2024 – WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, has unveiled its WCG Clinical Research Trends & Insights 2024 report. There is continued focus on protecting the rights and safety of participants and prioritizing diversity in the clinical trials space.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

XTalks

FEBRUARY 8, 2024

In industries that shape our daily lives, from life sciences and healthcare to medical devices, this day serves as a powerful reminder of the transformative impact of women and girls in science and the ongoing journey towards a more inclusive and equitable scientific community.

Life Science 105

Life Science Scientist Gene Editing Research 105

XTalks

APRIL 24, 2024

This month-long observance is not just a symbolic gesture; it’s a critical opportunity to take a deeper dive to open up dialogue and cast our focus on disparities, promote health equity and catalyze meaningful change. While the road to health equity may be long and challenging, it is a journey worth embarking on.

Research 87

Research Allergies Clinical Trials Clinical Trials 87

Sciensano

NOVEMBER 28, 2023

Objectives set to leave a lasting legacy JACARDI will test and offer solutions throughout the entire patient journey , including prevention, early detection, treatment, care, and self-management in order to reach the following objectives: Enhance health literacy and raise awareness about CVD and diabetes among the general population.

Development 98

Development Marketing Research 98

ACRP blog

AUGUST 9, 2023

These PIs also indicated that the field of clinical research itself isn’t diverse or representative of the population served. However,” they write, “historically, these trials have lacked diversity in participant representation, posing challenges in determining the safety and efficacy of treatments for specific populations.

Trials 98

Trials Clinical Trials Clinical Trials Clinical Research 98

WCG Clinical

MAY 9, 2023

WCG’s quality, operations, and diversity, equity and inclusion subject matter experts identify potential areas of risk in conjunction with its vast network of investigators, sites, and patient advocacy groups to ensure all key stakeholder input is received. Princeton, N.J. –

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Trials 52

XTalks

JANUARY 22, 2024

The most recent infusion of capital occurred on March 1, 2022, coming from a round of private equity investment. Healthmine’s Unique Approach Distinctively, Healthmine is the only tech company in the market that combines expert healthcare consulting with solutions for member engagement and experience.

Compliance 59

Compliance Marketing Development 59

Intouch Solutions

JANUARY 27, 2023

Today, let’s talk about one of those pressing issues: equity. The need for equity isn’t a fad or a novelty. EQUITY FOCUS In current work for an HIV brand, EVERSANA INTOUCH Proto has ensured that its efforts include people who are truly reflective of the patient population at every step, from ideation to creative to outreach. “We

Clinical Trials 52

Clinical Trials Clinical Trials Marketing Life Science 52

ACRP blog

JANUARY 26, 2023

Clinical trial sites that offer their study volunteers travel-related reimbursement and services, translated documents and translator services, and adequate compensation can have the most impact in terms of achieving diverse enrollment of participants, according to a new survey by a quartet of clinical researchers. View complete schedule.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Nurses 52

WCG Clinical

MAY 22, 2023

Despite the growing consensus around the need for diversity in clinical trials, the industry still has a long way to go. Despite the growing consensus around the need for diversity in clinical trials, the industry still has a long way to go. Growing evidence suggests this is not the case.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Cardiology 52

ACRP blog

AUGUST 9, 2023

These PIs also indicated that the field of clinical research itself isn’t diverse or representative of the population served. However,” they write, “historically, these trials have lacked diversity in participant representation, posing challenges in determining the safety and efficacy of treatments for specific populations.

Trials 52

Trials Clinical Trials Clinical Trials Clinical Research 52

pharmaphorum

FEBRUARY 7, 2022

Pharmaceutical Research and Manufacturers of America (PhRMA) added diversity guidelines to their clinical trial conduct guidelines around the same time. The cloud-based software helps pharma companies find diverse patient populations and meet them where they’re seeking care. “So,

Clinical Trials 89

Clinical Trials Clinical Trials Trials Pharma Companies 89

WCG Clinical

JANUARY 4, 2024

Diversity, Equity & Inclusion Decentralized & Hybrid Trials Research Site Readiness Emerging Opportunities Diversity, Equity & Inclusion Lack of diversity in clinical trials can impair quality, increase costs, and put patient safety at risk.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Clinical Research 59

XTalks

AUGUST 4, 2022

Cardiovascular clinical trials need to have a diversity plan because there can be a difference in disease burden when comparing people of different race and ethnicity. The US Food and Drug Administration (FDA) is emphasizing the need for diversity in clinical trials. The Diversity of the US Population.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

WCG Clinical

JULY 11, 2023

Lack of diversity in clinical trials can impair quality, increase costs, and put patient safety at risk. The barriers to diversity have been well-documented, but, despite significant progress, the industry still struggles to overcome them. You want your clinical trial population to reflect your product’s future consumers. We can help.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

ACRP blog

AUGUST 2, 2023

Implement diversity, equity, and inclusion (DE&I) strategies into your participant recruitment, enrollment, and retention processes. Utilize and invest in technology systems that can improve existing workflows and streamline research operations.

Trials 52

Trials Clinical Research Clinical Trials Clinical Trials 52

ACRP blog

AUGUST 2, 2023

Implement diversity, equity, and inclusion (DE&I) strategies into your participant recruitment, enrollment, and retention processes. Utilize and invest in technology systems that can improve existing workflows and streamline research operations.

Trials 52

Trials Clinical Research Clinical Trials Clinical Trials 52

pharmaphorum

JULY 19, 2021

Comprehensive policy solutions are needed to help ensure a sustainable pipeline for new treatment, including advancing payment reforms that remove disincentives for appropriate use of antimicrobial medicines, and creating incentives to promote the development of new antimicrobial treatments and rapid diagnostics.”. “We Building back better.

Clinical Trials 105

Clinical Trials Clinical Trials Medicine Manufacturing 105

ACRP blog

MAY 18, 2023

In this fifth blog in a series observing Asian American and Pacific Islander (AAPI) Heritage Month in May, three members of ACRP’s Northern California Chapter offer their thoughts on improving inclusion of these populations in clinical research. Gulati is President and Executive Board Member of the ACRP–Northern California Chapter. “It

Clinical Research 52

Clinical Research Clinical Trials Clinical Trials Research 52

Velocity Clinical Research

JANUARY 23, 2023

1: Consolidation and scale of the market It is well known that fragmentation of the clinical sites business has been identified as a market opportunity by private equity firms. 3: Inclusivity not diversity Moving the needle on inclusivity in clinical trials is not easy but the industry will continue to prioritize it.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

XTalks

JULY 29, 2021

Just as clinical researchers in other therapeutic areas have renewed their commitment to improving participant diversity in clinical trials, so too have those working in Alzheimer’s research. Hill, Alzheimer’s Association chief diversity, equity and inclusion officer, in a press release.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Research 98

ACRP blog

OCTOBER 5, 2022

It made me determined to be part of the solution,” she recalls. We need to address the lack of diversity in the clinical trial patient population and increase [diversity, equity, and inclusion] in the clinical trial workforce,” she says. Martin, MS, DrPH, associate director for site management and monitoring (U.S.)

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Trials 52

ACRP blog

OCTOBER 6, 2022

The total percentage of minority inclusion from all clinical trials in the United States during the last 25 years was just 3.95%. [1]. Fox Foundation (MJFF) staff discuss the critical need to engage diverse people in clinical studies of the disease. Fox Foundation to Expand Diversity in Parkinson’s Research appeared first on ACRP.

Research 98

Research Clinical Trials Clinical Trials Trials 98

The Pharma Data

MAY 22, 2023

Continuing to improve the diversity of Lilly’s workforce with minority group members now serving in a quarter of all management positions in the U.S. – Diversity, equity and inclusion (DEI) continue to be a priority for Lilly. and women serving in nearly half (49%) of all management positions globally. .”

Insulin 52

Insulin Medicine Clinical Trials Clinical Trials 52

Pfizer

APRIL 4, 2023

Over the next two decades, we’ll be living through a scientific renaissance driven by advancements in biology and technology that will come together and produce solutions on a great scale. “I couldn’t be more excited about Pfizer’s future or the potentially game-changing impact our innovations will have on patients,” said Bourla.

Life Science 97

Life Science Vaccination Vaccine Branding 97

XTalks

MAY 11, 2023

Society is comprised of people from diverse backgrounds, ethnicities, gender identities, sexualities, races and religions, as well as physical and mental capabilities. As part of a diverse society, webinars should ideally be accessible to as many people as possible, including those who are living with hearing disabilities.

Marketing 98

Marketing Production Life Science Regulation 98

Pfizer

MARCH 28, 2023

We strive to help close that gap, acknowledging that there is no one-size-fits-all solution,” says Caroline Roan, Senior Vice President, Global Health & Social Impact at Pfizer and President of The Pfizer Foundation. Global Dashboard for Vaccine Equity. The Pfizer Foundation is a charitable organization established by Pfizer Inc.

Vaccination 98

Vaccination Vaccine Medicine Pharmacy 98

ACRP blog

SEPTEMBER 11, 2023

vii] Economic Considerations Investigators and sponsors can use AI and specific algorithms to identify diverse patient populations most suited for the study without proximity limitations, thus allowing them to streamline high-expense areas of trial recruitment. 2022 “Strategies to Advance Equity in Cancer Clinical Trials.” 42:127-137.

Clinical Trials 69

Clinical Trials Clinical Trials Trials Drugs 69

pharmaphorum

JANUARY 17, 2022

The opportunity to implement such solutions has evolved rapidly over time, as the public, in general, are much more comfortable using and living with technology that can assist in DCTs, such as smartphones or smart devices. Greater inclusion. The post Decentralised trials: beyond the pandemic appeared first on.

Trials 105

Trials Clinical Trials Clinical Trials Clinical Research 105

Pfizer

FEBRUARY 1, 2023

Increasing diversity in clinical trials is a major way to address disparities in care from the beginning of the medicine’s lifecycle. Through collaborations with advocacy organizations, such as our partnership with the Tigerlily Foundation, we are working to make breast cancer clinical trials more inclusive for women of color. “If

Clinical Trials 98

Clinical Trials Clinical Trials Medicine Trials 98

Drug Channels

OCTOBER 23, 2023

Do not miss your chance to join seasoned leaders, your peers and leading solution providers as they dive into the top trends for innovative distribution, integrated pharmacy models and the future of trade. In just three days, walk away with answers to these questions and more from experts from across the industry. What can you expect?

Pharmacy 62

Pharmacy Marketing Production Branding 62

WCG Clinical

JUNE 12, 2023

They reported 30% reduction in clinical endpoints 20% fewer inclusion/exclusion criteria 50% reduction in the amount of data collected Engaging your PAB in a 360-degree review of your protocol can help you identify ways to make a trial more efficient, less burdensome and more accessible.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

OCTOBER 18, 2022

Listening to patients, patient advocacy groups, and others allows for better design of trial protocols, shaping tailored recruiting strategies, and helping to define what DCT solutions, including technologies, may most effectively and efficiently keep patients interested in, helping successful drug development to continue.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

The Pharma Data

SEPTEMBER 7, 2021

The shared commitment is rooted in creating inclusive opportunities for members of this community and making camperships accessible for all children with T1D. This effort is part of a greater commitment from Lilly to increase access, equity, and impact for the communities it serves.

Insulin 52

Insulin Hormones Manufacturing Medicine 52

The Pharma Data

MAY 4, 2021

” Lilly ‘s focus areas for ESG include access and affordability, diversity and inclusion, community engagement, employee well-being, human rights, patient safety, climate, waste, water, product stewardship, corporate governance, business ethics and supply chain management. Diversity and Inclusion.

Medicine 52

Medicine Insulin Containment Production 52

pharmaphorum

DECEMBER 18, 2020

COVID-19 has laid the UK’s health inequalities bare and created an imperative for the NHS to develop a step-change in how it cares for diverse and marginalised communities. Health inequality is the “greatest societal challenge of our time”, according to a briefing document calling for a system-wide solution.

Development 61

Development Vaccination Vaccine Research 61

Pfizer

APRIL 14, 2023

Thanks to the incredible partnership and all of those who have been involved in COVAX, we have a truly global solution to fight this pandemic. As Pfizer and BioNTech and then other manufacturers bring their vaccines to COVAX, we grow more powerful in the fight against this virus and get closer to achieving #OneWorldProtected.

Vaccination 52

Vaccination Vaccine Development Manufacturing 52